Cargando…
Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality
Coronavirus disease (COVID-19) reached pandemic proportions at the beginning of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory distress syndrome are the leading causes of death in severely or critically ill patients. The elevated cytokine levels in severe patien...
Autores principales: | Moradian, Negar, Gouravani, Mahdi, Salehi, Mohammad Amin, Heidari, Arash, Shafeghat, Melika, Hamblin, Michael R., Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Libbey Eurotext
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792554/ https://www.ncbi.nlm.nih.gov/pubmed/33361013 http://dx.doi.org/10.1684/ecn.2020.0451 |
Ejemplares similares
-
How Stable Ischemic Heart Disease Leads to Acute Coronary Syndrome in COVID-19?
por: Shafeghat, Melika, et al.
Publicado: (2021) -
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
por: Fara, Antonella, et al.
Publicado: (2020) -
Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils
por: Al-Muhsen, Saleh, et al.
Publicado: (2013) -
Pro- and Anti-Inflammatory Cytokines Release in Mice Injected with Crotalus durissus terrificus Venom
por: Hernández Cruz, A., et al.
Publicado: (2008) -
Identification of (poly)phenol treatments that modulate the release of
pro-inflammatory cytokines by human lymphocytes
por: Ford, Christopher T., et al.
Publicado: (2016)